Technology Landscape, Trends and Opportunities in the Global Implantable Device Market

The material technologies in implantable device has undergone significant change in recent years, with metal to ceramic based implantable device. The rising wave of new material technologies such as metallic and ceramic bio material are creating significant potential for advanced implantable device in various medical platforms due to its favorable mechanical strength, excellent friction-resistance, biocompatibility, and durability.

In implantable device market, various material technologies such as polymer, metal, ceramic, and biologics are used in the orthopedic, dental, facial, breast, and cardiovascular implant applications. Growing elderly population, rise in prevalence of chronic diseases, and rise in incidence of obesity and osteoporosis-related fractures are creating new opportunities for various implantable device technologies.

Some of the latest technological developments by various countries in the implantable device market are as follows:

• United States: Medtronic announced FDA approval of their new dissolvable polymer stent designed to treat coronary artery blockages. This minimally invasive technology aims to reduce long-term complications associated with permanent stents. Zimmer Biomet, a leading orthopedic implant manufacturer, is investing heavily in research on bone graft substitutes using 3D-printed biocompatible scaffolds. This technology has the potential to revolutionize bone regeneration procedures.
• China: Chinese companies like Beijing Wanxiang Qianfeng are focusing on developing affordable and high-quality metal knee and hip implants. Government initiatives are promoting domestic production to reduce reliance on foreign imports.
• Germany: CeramTec is at the forefront of developing ceramic spinal implants that offer superior biocompatibility and wear resistance compared to traditional metal options. This research is expected to improve the long-term success rates of spinal fusion surgeries.

This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the implantable device market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.





The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global implantable device technology by application, technology, and region as follows:

Technology Readiness by Material Technology

Competitive Intensity and Regulatory Compliance

Disruption Potential by Material Technology

Trends and Forecasts by Material Technology [$M shipment analysis from 2018 to 2030]:

• Polymer Based
• Metal Based
• Ceramic Based
• Biologics

Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:

• Orthopedic Implant
  • Polymer Based
  • Metal Based
  • Ceramic Based
  • Biologics
• Dental Implant
  • Polymer Based
  • Metal Based
  • Ceramic Based
  • Biologics
• Facial Implant
  • Polymer Based
  • Metal Based
  • Ceramic Based
  • Biologics
• Breast Implant
  • Polymer Based
  • Metal Based
  • Ceramic Based
  • Biologics
• Cardiovascular Implant
  • Polymer Based
  • Metal Based
  • Ceramic Based
  • Biologics

Technology Trends and Forecasts by Region [$M shipment analysis for 2018 – 2030]:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • South Korea
  • India
• The Rest of the World

Latest Developments and Innovations in the Implantable Device Technologies

Companies / Ecosystems

Strategic Opportunities by Material Technology

Some of the implantable device companies profiled in this report include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Cardinal Health, Conmed Corporation, Globus Medical, Integra Lifesciences Holdings Corporation, Johnson & Johnson, and LivaNova.

Below are the latest technological developments from top companies in the implantable device market:

• Johnson & Johnson (J&J) received FDA approval for their new generation of XELIUS™ hip implant, featuring a proprietary polymer coating designed to improve wear resistance and longevity.
• Stryker Corporation announced a $50 million capital expenditure plan to expand their manufacturing capacity for BioFlex® patient-specific knee implants, a polymer-based solution for total knee replacements.
• Zimmer Biomet partnered with the National Institute of Standards and Technology (NIST) to develop new standards for characterizing the surface properties of metal-based knee implants, aiming to improve long-term performance.
• The German Federal Ministry of Education and Research awarded ExplantLab a grant to develop a novel metal-based spinal implant with an antibacterial surface coating, potentially reducing infection risks.
• CeramTec GmbH launched their CeraDur® Acetabular Cup System, a ceramic-on-ceramic hip replacement solution boasting exceptional wear resistance and biocompatibility.
• Smith & Nephew received regulatory approval in China for their OXinium® zirconia knee implant, expanding their reach in the high-growth Asian market for ceramic-based implants.
• Medtronic acquired InBone Technologies, a company specializing in bone graft substitutes derived from natural biomaterials, strengthening their position in the biologics segment.
• Ossur partnered with a consortium of universities in Europe to research and develop next-generation biocompatible materials for spinal fusion procedures.

This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the implantable device market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in implantable device market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in implantable device market?
Q.6 What are the latest developments in implantable device technologies? Which companies are leading these developments? 
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this implantable device market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this implantable device technology space?